Access cutting-edge ewing sarcoma treatment through this clinical trial at a research site in Washington Dc. Study-provided care at no cost to qualified participants.
Access ewing sarcoma specialists in Washington Dc at no cost
This study follows strict safety protocols and ethical guidelines
All study-related ewing sarcoma treatment provided free
This study is conducted in two phases. The phase 1 portion of the study evaluates the safety, tolerability, pharmacokinetics (PK), recommended phase 2 dose (RP2D), and effectiveness of lurbinectedin monotherapy in pediatric participants with previously treated solid tumors. This is followed by the phase 2 portion, to further assess the effectiveness and safety in pediatric and young adult participants with recurrent/refractory Ewing sarcoma.
Sponsor: Jazz Pharmaceuticals
Check if you qualify for this ewing sarcoma clinical trial in Washington Dc, DC
If you're searching for ewing sarcoma treatment options in Washington Dc, DC, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Washington Dc research site is actively enrolling participants for this clinical trial. You'll receive care from experienced ewing sarcoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.